Michael Lofthagen, Founder
Michael Lofthagen has more than two decades of experience from the pharmaceutical industry. After completing his B.Sc. degree in organic chemistry at the University of Lund, Sweden in 1985 Michael joined Ferring Pharmaceutical where he worked on route discovery for the nona-petide DDAVP. He then completed a PhD in Jay Siegels Group at the University of California, San Diego and graduated in 1992. Michael returned to Sweden to take a position in the Process R&D group at AstraZeneca (formerly Astra) where he worked to bring new drugs to market such as Nexium and Oxeeze TBH. In 1998, Michael Lofthagen and Paul Alhadeff started Syntagon.
Paul Alhadeff, Founder
Paul Alhadeff has more than two decades of industry experience with Pharmacia, AstraZeneca and Syntagon . Paul completed his B.Sc. degree in organic chemistry at the University of Stockholm, Sweden, in 1989. During his career, he has worked to bring several new drugs to the market including Oxeeze TBH and Symicort. Paul was also instrumental in driving the technology transfer process of API manufacturing from R&D to production scale. In addition, he was in charge of the outsourcing of several processes and set up new standards for outsourcing within AstraZeneca (formerly Astra). In 1998, Paul Alhadeff and Michael Lofthagen started Syntagon.